3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
15
Breast Neoplasms
6
Neoplasm Metastasis
5
Nasopharyngeal Carcinoma
4
Carcinoma, Non-Small-Cell Lung
4
Stomach Neoplasms
2
Neoplasms
2
Malnutrition
2
Colonic Neoplasms
2
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrent Squamous Cell Lung Carcinoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Nonsquamous Nonsmall Cell Neoplasm of Lung
1
Neurotoxicity Syndromes
1
Neoplastic Cells, Circulating
1
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
1
Metastatic Hormone-sensitive Prostate Cancer
1
Metastatic Castration Resistant Prostate Cancer
1
Lung Neoplasms
1
Liver Neoplasms
1
Gallbladder Neoplasms
1
Fatigue
1
Esophageal Neoplasms
1
Chemotherapy-induced Peripheral Neuropathy
1
CYP3A Phenotyping
1
Biliary Tract Neoplasms
1
Interventions
darolutamide
2
Docetaxel
1
Androgen Antagonists
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
×
Docetaxel
×
Clear all
NCT06661122
2026-05-19
HAYATE
Bayer
Recruiting
100 enrolled